This Is What Whales Are Betting On Insulet

Someone with a lot of money to spend has taken a bearish stance on Insulet PODD.

And retail traders should know.

We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Whether this is an institution or just a wealthy individual, we don't know. But when something this big happens with PODD, it often means somebody knows something is about to happen.

Today, Benzinga's options scanner spotted 10 options trades for Insulet.

This isn't normal.

The overall sentiment of these big-money traders is split between 20% bullish and 80%, bearish.

Out of all of the options we uncovered, 9 are puts, for a total amount of $743,059, and there was 1 call, for a total amount of $28,225.

Get Started

Earn 7.2% — No Matter What the Fed Does

Markets expect rate cuts — but your earnings don’t have to suffer. Lock in 7.2% until 2028 from ten individual bonds.

Get Started

What's The Price Target?

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $150.0 to $230.0 for Insulet over the last 3 months.

Volume & Open Interest Development

Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Insulet's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Insulet's whale trades within a strike price range from $150.0 to $230.0 in the last 30 days.

Insulet Option Volume And Open Interest Over Last 30 Days

Biggest Options Spotted:

Where Is Insulet Standing Right Now?

• With a volume of 1,447,783, the price of PODD is down -10.35% at $173.38.
• RSI indicators hint that the underlying stock may be oversold.
• Next earnings are expected to be released in 56 days.

What The Experts Say On Insulet:

• TD Cowen has decided to maintain their Outperform rating on Insulet, which currently sits at a price target of $300.
• JP Morgan has decided to maintain their Overweight rating on Insulet, which currently sits at a price target of $325.
• B of A Securities has decided to maintain their Buy rating on Insulet, which currently sits at a price target of $295.
• Wells Fargo has decided to maintain their Overweight rating on Insulet, which currently sits at a price target of $330.
• Citigroup upgraded its action to Buy with a price target of $265

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you want to stay updated on the latest options trades for Insulet, Benzinga Pro gives you real-time options trades alerts.